# SOPHiA GENETICS

Source: https://onco.cc/companies/sophia-genetics/  
OnCo record `sophia-genetics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cloud platform (SOPHiA DDM) that hospitals use to analyse and interpret NGS oncology panels.

## Summary

SOPHiA GENETICS, based in Rolle, Switzerland, and listed as SOPH, provides the SOPHiA DDM cloud platform that hospitals use to analyse and interpret next-generation sequencing oncology panels. Its decentralised model lets laboratories sequence locally and interpret in the cloud, and it runs multimodal research programmes combining imaging with genomics. OnCo links it to clinical NGS bioinformatics and variant interpretation. Whether decentralised sequencing with centralised interpretation gives results as consistent as sending samples to one large laboratory is the open question. The bioinformatics technology page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Rolle
- Type: ai-software
- Website: https://www.sophiagenetics.com
- Ticker: SOPH

## Sources

- Official website: https://www.sophiagenetics.com

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Clinical NGS bioinformatics and variant interpretation](https://onco.cc/technologies/ngs-bioinformatics-software/), [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/)

---
JSON: https://onco.cc/api/v1/entities/sophia-genetics.json